HYFT

Healthcare Biotechnology

MindWalk Holdings Corp.

$1.55

+0.03 +1.97% today

Price History

Not enough data

Key Stats

Market Cap

73.02M

Avg Volume

227,501

EPS

-$0.26

52W High

$2.99

52W Low

$0.99

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

P/B Ratio

15.02

P/S Ratio

4.50

EV/EBITDA

-4.28

EV/Revenue

4.24

Margins

Gross Margin 60.8%

Operating Margin (159.9%)

Net Margin (105.2%)

EBITDA Margin (99.2%)

Growth & Returns

Revenue Growth (YoY)

21.3%

Return on Equity

(123.7%)

Return on Assets

(36.4%)

Liquidity & Leverage

Current Ratio

1.84

Quick Ratio

1.63

Debt / Equity

0.50

Total Cash

7.62M

Total Debt

3.48M

About

MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.